With its closed cell design, blueflow Venous Stent is highly flexible. The blueflow Venous Stent is available in different configurations. Many people suffer from venous diseases. Varicose veins and spider veins are terms that almost everyone knows. If varicose veins or even venous ulcers (Ulcus Cruris) occur again despite a varicose vein treatment, these are often the consequences of an obstruction in the pelvic vein caused by a thrombosis.
In the course of thrombosis in the pelvic vein, scarring and obstruction often occur. Since the venous valves are involved, they can lose their function. This leads to blood congestion in the legs.
Typical consequences of pelvic vein obstruction or occlusion are varicose veins, painful swelling of the legs, calf cramps and poorly healing venous ulcers.
Modern, non-invasive diagnostic procedures can precisely locate these obstruction and occlusions.
If an acute or chronically occluded or severely obstructed pelvic vein has been diagnosed as the cause, it can be reopened by a minimally invasive catheter procedure.
In the pelvic vein area, a venous stent is then advanced under radiological control up to the narrow point and released there. In the case of extensive occlusions, it is sometimes necessary to implant several or one long stent.
Due to the reopening of the pelvic vein the blood flow in the direction of the heart is improved. This reduces the backflow in the legs and thus the pressure on the tissue. After this treatment, open ulcers have the chance to heal and massive swelling of the legs can be reduced. The reopening of occluded pelvic veins is a complex procedure that requires a great deal of experience and a venous stent that fulfils special requirements.
These minimally invasive procedures are performed in special centers.
The blueflow Venous Stent was developed and produced in Germany in cooperation with leading international vein specialists.
It is now marketed worldwide.
The blueflow Venous Stent is characterized by its extreme flexibility and kink and compression resistance.
Due to the special processing technology, the blueflow Venous Stent adapts to the natural course of the vessel and does not kink during everyday movements.
Maximum compression resistance and flexibility are the most important criteria for venous stents implanted below the inguinal ligament.
Since our beginnings we have always worked with quality products and we have experienced professionals allowing maximum grade in order to be always at the forefront.
All our products are high-tech standards, with innovation and keeping a strong presence in international markets.
cNovate Medical BV operates globally and specializes in the research, development, manufacturing and sales of cardiovascular and endovascular treatment devices.
We are not working alone. Part of our success is due to working closely with customers, patients, industry partners, leaders and government agencies to realize the vision of better, simpler and more accessible healthcare.
PulseCath® is focused on developing ground-breaking technologies designed to assist the life sustaining pumping functions of the failing heart.
PulseCath BV. is a Netherlands based medical device company that develops, manufactures and markets circulatory support systems. The company, formed in 2007, has developed unique and proprietary platform technology to provide a short-term circulatory support system for cardiologists and cardiac surgeons.
Super selective and targeted embolizations
Interventional Radiologists are finding confidence through a greater sense of predictability while using Varian microspheres. Designed with elasticity to allow smooth delivery and size calibrated to enable deep tumor coverage, our array of tightly calibrated bead sizes is expanding the possibilities of embolization procedures and the type of patients that can benefit.
The blueflow Venous Stent is indicated for the treatment of venous outflow obstructions in the lower extremities. With its closed cell design, blueflow Venous Stent is highly flexible. The blueflow Venous Stent is available in different configurations.
Many people suffer from venous diseases. Varicose veins and spider veins are terms that almost everyone knows. If varicose veins or even venous ulcers (Ulcus Cruris) occur again despite a varicose vein treatment, these are often the consequences of an obstruction in the pelvic vein caused by a thrombosis.
Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper® balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. Embolx is a privately held company.